MRK
25
-2
YUM
47
3
GPC
40
3
WU
32
2
FDX
43
3
STI
14
-17
AMG
54
2
CSX
60
3
WM
79
3
EQT
57
-2
WEC
53
-2
CINF
53
2
COF
60
2
PFE
23
7
PAYX
53
2
DFS
64
2
NKE
36
6
SYY
53
4
DTE
56
2
SO
53
-4
MRK
25
-2
YUM
47
3
GPC
40
3
WU
32
2
FDX
43
3
STI
14
-17
AMG
54
2
CSX
60
3
WM
79
3
EQT
57
-2
WEC
53
-2
CINF
53
2
COF
60
2
PFE
23
7
PAYX
53
2
DFS
64
2
NKE
36
6
SYY
53
4
DTE
56
2
SO
53
-4
Financhill
Back

Adverum Biotechnologies Vs. Editas Medicine Industry Stock Comparison

Sell
35

ADVM
Adverum Biotechnologies

Last Price:
6.05
Seasonality Move:
22.26%
Sell
40

EDIT
Editas Medicine

Last Price:
2.44
Seasonality Move:
13.73%
Sell
35
Adverum Biotechnologies (ADVM) is a Sell

Is Adverum Biotechnologies a Buy, Sell or Hold?

  • The current Adverum Biotechnologies [ADVM] share price is $6.04. The Score for ADVM is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • ADVM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $2.44. The Score for EDIT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ADVM Stock Price Chart

What is Adverum Biotechnologies's stock price today?

  • The Adverum Biotechnologies share price today is $6.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADVM is experiencing buying pressure, which is a positive indicator for future bullish movement.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $2.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight buying pressure.

ADVM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 31.12 Sell
Chaikin Money Flow: 229906 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.74 - 8.16) Sell
Bollinger Bands (100): (6.72 - 8) Sell

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 33.29 Sell
Chaikin Money Flow: 166015 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.64 - 3.32) Sell
Bollinger Bands (100): (2.97 - 4.75) Sell

ADVM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.59 Sell
20-day SMA: 7.29 Sell
50-day SMA: 7.4 Sell
200-day SMA: 9.82 Sell
8-day EMA: 6.5 Sell
20-day EMA: 7.05 Sell
50-day EMA: 7.32 Sell
200-day EMA: 8.77 Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.58 Sell
20-day SMA: 2.89 Sell
50-day SMA: 3.21 Sell
200-day SMA: 5.21 Sell
8-day EMA: 2.58 Sell
20-day EMA: 2.83 Sell
50-day EMA: 3.21 Sell
200-day EMA: 4.98 Sell

Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.56 per share, and an increase next year of $0.34 per share.

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.23 per share.

Adverum Biotechnologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):